The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis.

Détails

Ressource 1Télécharger: 34958182_BIB_FF7D93901041.pdf (448.32 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_FF7D93901041
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis.
Périodique
Hepatology communications
Auteur⸱e⸱s
Innes H., Nischalke H.D., Guha I.N., Weiss K.H., Irving W., Gotthardt D., Barnes E., Fischer J., Ansari M.A., Rosendahl J., Lin S.K., Marot A., Pedergnana V., Casper M., Benselin J., Lammert F., McLauchlan J., Lutz P.L., Hamill V., Mueller S., Morling J.R., Semmler G., Eyer F., von Felden J., Link A., Vogel A., Marquardt J.U., Sulk S., Trebicka J., Valenti L., Datz C., Reiberger T., Schafmayer C., Berg T., Deltenre P., Hampe J., Stickel F., Buch S.
ISSN
2471-254X (Electronic)
ISSN-L
2471-254X
Statut éditorial
Publié
Date de publication
05/2022
Peer-reviewed
Oui
Volume
6
Numéro
5
Pages
1213-1226
Langue
anglais
Notes
Publication types: Journal Article ; Meta-Analysis
Publication Status: ppublish
Résumé
The host genetic background for hepatocellular carcinoma (HCC) is incompletely understood. We aimed to determine if four germline genetic polymorphisms, rs429358 in apolipoprotein E (APOE), rs2642438 in mitochondrial amidoxime reducing component 1 (MARC1), rs2792751 in glycerol-3-phosphate acyltransferase (GPAM), and rs187429064 in transmembrane 6 superfamily member 2 (TM6SF2), previously associated with progressive alcohol-related and nonalcoholic fatty liver disease, are also associated with HCC. Four HCC case-control data sets were constructed, including two mixed etiology data sets (UK Biobank and FinnGen); one hepatitis C virus (HCV) cohort (STOP-HCV), and one alcohol-related HCC cohort (Dresden HCC). The frequency of each variant was compared between HCC cases and cirrhosis controls (i.e., patients with cirrhosis without HCC). Population controls were also considered. Odds ratios (ORs) associations were calculated using logistic regression, adjusting for age, sex, and principal components of genetic ancestry. Fixed-effect meta-analysis was used to determine the pooled effect size across all data sets. Across four case-control data sets, 2,070 HCC cases, 4,121 cirrhosis controls, and 525,779 population controls were included. The rs429358:C allele (APOE) was significantly less frequent in HCC cases versus cirrhosis controls (OR, 0.71; 95% confidence interval [CI], 0.61-0.84; P = 2.9 × 10 <sup>-5</sup> ). Rs187429064:G (TM6SF2) was significantly more common in HCC cases versus cirrhosis controls and exhibited the strongest effect size (OR, 2.03; 95% CI, 1.45-2.86; P = 3.1 × 10 <sup>-6</sup> ). In contrast, rs2792751:T (GPAM) was not associated with HCC (OR, 1.01; 95% CI, 0.90-1.13; P = 0.89), whereas rs2642438:A (MARC1) narrowly missed statistical significance (OR, 0.91; 95% CI, 0.84-1.00; P = 0.043). Conclusion: This study associates carriage of rs429358:C (APOE) with a reduced risk of HCC in patients with cirrhosis. Conversely, carriage of rs187429064:G in TM6SF2 is associated with an increased risk of HCC in patients with cirrhosis.
Mots-clé
Apolipoproteins E/genetics, Carcinoma, Hepatocellular/genetics, Genetic Predisposition to Disease, Hepatitis C/complications, Humans, Liver Cirrhosis/genetics, Liver Neoplasms/genetics, Membrane Proteins/genetics, Polymorphism, Single Nucleotide/genetics
Pubmed
Web of science
Open Access
Oui
Création de la notice
04/01/2022 8:30
Dernière modification de la notice
23/01/2024 7:38
Données d'usage